Differential gene expression in normal human mammary epithelial cells treated with malathion monitored by DNA microarrays

Environmental Health Perspectives

Volumn 113, Issue 8, 2005, Pages 1046-1051

  Gwinn, Maureen R ^a   Whipkey, Diana L ^a   Tennant, Lora B ^a   Weston, Ainsley ^a  

^a Health Effects Laboratory Division   (United States)

Author keywords

DNA microarray; Gene expression; Malathion; Pesticide; Toxicology

Indexed keywords

BIOLOGICAL MARKER; CHECKPOINT KINASE 1; DNA; MALATHION; NUCLEAR PROTEIN; ORGANOPHOSPHATE; OXIDOREDUCTASE; PESTICIDE; PLASMINOGEN ACTIVATOR; REPLICATION FACTOR C; RNA; THYMIDYLATE SYNTHASE;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; BREAST EPITHELIUM; BREAST RECONSTRUCTION; CARCINOGENICITY; CELL STRAIN; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM CELL; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; TISSUE SECTION;

EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INSECTICIDES; MALATHION; MAMMARY GLANDS, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

WEST NILE VIRUS;

EID: 23844446675     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7311     Document Type: Review

References (39)

1. Affymetrix. 2001. GeneChip Expression Analysis Technical Manual, version 1. Santa Clara, CA:Affymetrix.
2. ATSDR. 2001. Toxicological Profile for Malathion [Draft for Public Comment]. Contract 205-1999-00024. Syracuse, NY:Syracuse Research Corporation (for the Agency for Toxic Substances and Disease Registry).
3. Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, et al. 1995. p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16(9):2233-2236.
4. Blasiak J, Jaloszynski P, Trzeciak A, Szyfter K. 1999. In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues. Mutat Res 445(2):275-283.
5. Bolognesi C. 2003. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res 543(3):251-272.
6. Duke SO, Baerson SR, Dayan FE, Rimando AM, Scheffler BE, Tellez MR, et al. 2003, United States Department of Agriculture - Agricultural Research Service research on natural products for pest management. Pest Manag Sci 59(6-7):708-717.
7. Dunican DS, McWilliam P, Tighe O, Parle-McDermott A, Croke DT. 2002. Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization. Oncogene 21(20):3253-3257.
8. Ellison V, Stillman B. 2003. Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5′ recessed DNA. PLoS Biol 1(2):E231-243.
9. Flatt PM, Polyak K, Tang LJ, Scatena CD, Westfall MD, Rubinstein LA, et al. 2000. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett 156(1):63-72.
10. Geigl JB, Langer S, Barwisch S, Pfleghaar K, Lederer G, Speicher MR. 2004. Analysis of gene expression patterns and chromosomal changes associated with aging. Cancer Res 64(23):8550-8557.
11. Gwinn MR, Whipkey DL, Weston A. 2004a. The effect of oxythioquinox exposure on normal human mammary epithelial cell gene expression: a microarray analysis study. Environ Health 3(1):9-19.
12. Gwinn MR, Whipkey DL, Tennant LB, Weston A. 2004b. Treated with malathion monitored by DNA microarrays. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/ext-supp-mat/weston/malathion/MALATHION.HTM [accessed 30 May 2004].
13. Jez JM, Flynn TG, Penning TM. 1997. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 54(6):639-647.
14. Kawamata H, Furihata T, Omotehara F, Sakai T, Horiuchi H, Shinagawa Y, et al. 2003. Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray. Cancer Sci 94(8):699-706.
15. Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A, Keshava N, et al. 2002. Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol Biomarkers Prev 11(1): 127-130.
16. Keshava C, Whipkey DL, Weston A. 2005. Transcriptional signatures of environmentally relevant exposures in normal human mammaray epithelial cells: benzo[a]pyrene. Cancer Lett 221(2):201-211.
17. 1 to complete the cell cycle. Proc Natl Acad Sci USA 91(17):8022-8026.
18. NYCDH. 1999. Press Release: Aerial Spraying of Pesticides. New York:New York City Department of Health. Available: http://www.ci.nyc.ny.us/html/doh/html/public/press99/pr51-909. html [accessed 31 December 2003].
19. Palackal NT, Lee SH, Harvey RG, Blair IA, Penning TM. 2002. Activation of polycyclic aromatic hydrocarbon transdihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional over-expression in human lung carcinoma (A549) cells. J Biol Chem 277(27):24799-24808.
20. Penning TM, Ohnishi ST, Ohnishi T, Harvey RD. 1996. Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dahydrogenase. Chem Res Toxicol 9(1):84-92.
21. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. 2002. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21(48):7435-7451.
22. Robles AI, Linke SP, Harris CC. 2002. The p53 network in lung carcinogenesis. Oncogene 21(45):6696-6907.
23. Saxena A, Maxwell DM, QuinnDM, Radic Z, Taylor P, Doctor BP. 1997. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning. Biochem Pharmacol 54:269-274.
24. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, et al. 1996. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17(6):1313-1316.
25. Smeds J, Berggren P, Ma X, Xu Z, Hemminki K, Kumar R. 2002. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation. Carcinogenesis 23(4):645-655.
26. Stampfer MR. 1985. Isolation and growth of human mammary epithelial cells. J Tissue Culture Methods 9:107-110.
27. Testa JR, Zhou JY, Bell DW, Yen TJ. 1994. Chromosomal localization at the genes encoding the kinetochore proteins CENPE and CENPF to human chromosomes 4q24 → q25 and 1q32 → q41, respectively, by fluorescence in situ hybridization. Genomics 23(3):691-693.
28. Titenko-Holland N, Windham G, Kolachana P, Reinisch F, Parvatham S, Osorio AM, et al. 1997. Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion-exposed workers. Mutat Res 388(1):85-95.
29. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. 2002. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111(3):299-302.
30. U.S. EPA. 2000a. Overview of Malathion Risk Assessment. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/oppsrrd1/op/malathion/overview.htm [accessed 31 December 2003).
31. U.S. EPA. 2003b. 1998-1999 Pesticide Market Estimates. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/oppbead1/pestsales/99pestsales/usage1999_3.html [accessed 31 December 2003].
32. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, et al. 2003. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163(3):1033-1043.
33. Waisfisz Q, Miyazato A, De Winter JP, Liu JM, Joenje H. 2002. Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays. BMC Blood Disord 2(1):5.
34. Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, et al. 1999. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer 81(1):179-183.
35. Weston A, Pan CF, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, et al. 1997. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6(2):105-112.
36. Windham GC, Titenko-Holland N, Osorio AM, Gettner S, Reinisch F, Haas R, et al. 1998. Genetic monitoring of malathion-exposed agricultural workers. Am J Ind Med 33(2):164-174.
37. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, et al. 2002. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94(9):681-690.
38. Yao LS, Li XP, Li Q, Zhang JH. 2002. Correlation of proliferating cell nuclear antigen expression with the clinical and biological characteristics and prognosis of hypopharyngeal carcinoma. Di Yi Jun Yi Da Xue Xue Bao 22(5):448-450.
39. Yih LH, Lee TC. 2003. Induction of C-anaphase and diplochromosome through dysregulation of spindle assembly checkpoint by sodium arsenite in human fibroblasts. Cancer Res 63(20):6680-6688.